Sonio builds AI-assisted ultrasound reporting software for prenatal screening, now operating as a Samsung Medison subsidiary since 2024. The stack (Python, SQL, MATLAB, DICOM, FHIR) reflects a healthcare-grade data platform optimized for medical imaging; the product carries FDA 510(k) clearance for diagnostic AI. Current hiring velocity is decelerating, with product and marketing roles open—signaling a shift from feature development toward implementation scaling and revenue operations, consistent with the 'scaling implementation capabilities' and 'synergy projects between sonio and samsung' appearing prominently in active work.
Sonio develops a customizable workflow and practice management platform for ultrasound practitioners and maternal-fetal medicine specialists. The product automates prenatal examination workflows, supports diagnostic accuracy through AI-powered detection, and generates standardized ultrasound reports. Built on over five years of research in fetal medicine and AI, the software is used by obstetrics and gynecology practices to streamline prenatal screening and ensure examination completeness. Sonio is headquartered in Boston, employs 51–200 people, and operates as a subsidiary of Samsung Medison Co., Ltd.
Python, SQL, MATLAB, DICOM, FHIR, HubSpot, Zendesk, and Excel. The medical-imaging-focused stack (DICOM for image data, FHIR for healthcare interoperability) reflects integration with hospital and clinic systems.
Headquartered in Boston, Massachusetts. Currently hiring in the United States and France. Founded in 2020 and acquired by Samsung Medison Co., Ltd in 2024.
Other companies in the same industry, closest in size